- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: PD-L1 Antibody
Total 10169 results
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Beijing Friendship HospitalNot yet recruiting
-
Hunan Cancer HospitalHenan Cancer Hospital; Chia Tai Tianqing Pharmaceutical Group Co., Ltd.RecruitingNon Small Cell Lung CancerChina
-
Nasser Hanna, M.D.Merck Sharp & Dohme LLC; Hoosier Cancer Research NetworkTerminatedGenital Neoplasms, Female | Testicular Neoplasms | Genital Neoplasms, Male | Ovarian Neoplasms | Mediastinal Neoplasms | Germ Cell Neoplasms | Non Seminomatous Germ Cell TumorsUnited States
-
The Second Affiliated Hospital of Harbin Medical...UnknownContract Management PD
-
Tasly Biopharmaceuticals Co., Ltd.Not yet recruitingNeoplasms MalignantChina
-
Hoffmann-La RocheActive, not recruitingHepatitis B, ChronicTaiwan, Canada, Korea, Republic of, Thailand, United Kingdom, China, United States, Bulgaria, Spain, New Zealand, Hong Kong, Romania, Chile, France
-
ETOP IBCSG Partners FoundationGlaxoSmithKline; Development LimitedRecruitingSCLC,Extensive Stage | SLFN11-positiveSwitzerland, France, Spain, Italy
-
National Cancer Institute (NCI)WithdrawnCastration Resistant Prostate CancerUnited States
-
Arjun Balar, MDHoosier Cancer Research Network; Roche-GenentechTerminatedUrothelial CarcinomaUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLCRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Metastatic Non-Small Lung Cell Cancer | Recurrent Non-Small Lung Cell CancerUnited States
-
Centre Leon BerardRoche Pharma AGRecruitingSarcoma,Soft TissueFrance, United Kingdom
-
National Cancer Institute (NCI)Not yet recruitingStage II Squamous Cell Carcinoma of the Head and Neck | Stage III Squamous Cell Carcinoma of the Head and Neck | Stage IV Squamous Cell Carcinoma of the Head and NeckUnited States
-
Gradalis, Inc.WithdrawnLung Neoplasms | Advanced Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerUnited States
-
Merck Sharp & Dohme LLCWithdrawnMultiple MyelomaUnited States, Canada, France, Israel, Spain, Sweden
-
Ruhr University of BochumUnknown
-
Philipp FürnstahlKU Leuven; Swiss Center for Musculoskeletal ImagingCompleted
-
Merck Sharp & Dohme LLCActive, not recruitingSmall Cell Lung CancerPoland, Russian Federation, United States, Austria, Canada, Hungary, Israel, Italy, Korea, Republic of, Spain, Switzerland
-
Mian XIRecruitingHepatocellular CarcinomaChina
-
Sichuan Cancer Hospital and Research InstituteNot yet recruitingNon-squamous Non-small Cell Lung Cancer | EGFR Gene MutationChina
-
National Cancer Center, KoreaRecruitingNon-small Cell Lung CancerKorea, Republic of
-
Samsung Medical CenterRecruitingMetastatic Non-Small Cell Lung CarcinomaKorea, Republic of
-
Effector TherapeuticsMedpace, Inc.; ICON plcActive, not recruitingNon-small Cell Lung CancerUnited States, Australia, Georgia
-
Bristol-Myers SquibbWithdrawnStage III or IV Melanoma
-
Novartis PharmaceuticalsTerminatedOvarian Cancer | Non-small Cell Lung Cancer (NSCLC) | Renal Cell Carcinoma (RCC) | Triple Negative Breast Cancer (TNBC) | Pancreatic Ductal Adenocarcinoma (PDAC) | Metastatic Castration Resistant Prostate Cancer (mCRPC) | Colorectal Cancer Microsatellite Stable (MSS)Canada, Australia, Singapore, United States, Japan, Spain, United Kingdom
-
Second Affiliated Hospital of Soochow UniversityNot yet recruiting
-
Merck Sharp & Dohme LLCCompletedMelanomaAustralia, South Africa, Spain, Sweden
-
Merck Sharp & Dohme LLCRecruitingNon-small Cell Lung Cancer (NSCLC)China, Australia, United States, Turkey, Chile, Taiwan, Denmark, France, Spain, Argentina, Italy, Netherlands, Thailand, Korea, Republic of
-
Merck Sharp & Dohme LLCRecruitingLymphoma, B-Cell | Lymphoma, Non-Hodgkin | Hodgkin DiseaseUnited States, Australia, Canada, Germany, Israel, Italy
-
Merck Sharp & Dohme LLCEisai Inc.CompletedNon-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingMetastatic Non-Small Cell Lung CancerRussian Federation, Australia, United States, Argentina, Canada, Colombia, France, Germany, Greece, Hungary, Israel, Italy, Japan, Korea, Republic of, Portugal, Puerto Rico, Spain, United Kingdom
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingNonsquamous Non-small Cell Lung CancerChina
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompleted
-
Merck Sharp & Dohme LLCCompletedMetastatic Castration-resistant Prostate Cancer
-
Merck Sharp & Dohme LLCCompleted
-
Asbjørn Mohr DrewesOdense University Hospital; Karolinska University Hospital; Hvidovre University... and other collaboratorsActive, not recruitingPancreatitis, AcuteDenmark, Sweden
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingNeoplasm, Esophageal | Neoplasm, Esophagus | Malignant Esophagus TumorNetherlands
-
Hoffmann-La RocheCompletedTumorsFrance, United States, Denmark, Ireland, Italy, Turkey, United Kingdom, Canada, Brazil, Spain, Poland, Netherlands, Germany, Russian Federation, Austria, Finland, Norway, Switzerland
-
Lee's Pharmaceutical LimitedRecruiting
-
Lee's Pharmaceutical LimitedRecruiting
-
Merck Sharp & Dohme LLCEisai Inc.Active, not recruitingHead and Neck Squamous Cell CarcinomaUnited States, Australia, Brazil, Canada, China, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Incyte Biosciences International SàrlRecruitingHead and Neck CancerUnited States, Taiwan, Italy, Korea, Republic of, Spain, France, Portugal, Germany, Poland, Canada, Georgia, Greece, Netherlands, Belgium
-
IO BiotechMerck Sharp & Dohme LLCCompletedNSCLCUnited Kingdom, Germany, Netherlands, Spain
-
Merck Sharp & Dohme LLCCompletedProstatic NeoplasmsUnited States, Argentina, Australia, Austria, Brazil, Canada, Chile, China, Colombia, France, Germany, Ireland, Israel, Italy, Japan, Korea, Republic of, Netherlands, Russian Federation, Spain, Taiwan, United Kingdom
-
King Faisal Specialist Hospital & Research CenterAstraZenecaCompleted
-
Hadassah Medical OrganizationRecruitingAminoglycoside Dosing Based on PK/PD CharacteristicsIsrael
-
Merck Sharp & Dohme LLCCompleted
-
National Cancer Institute (NCI)RecruitingCarcinoma, Non-Small-Cell Lung | Non-Small Cell Lung Cancer | Non-Small Cell Lung Carcinoma | CarcinomasUnited States